ANTICHOLIUM
ANTICHOLIUM solution for injection or infusion
Approved
Approval ID
b90b50e8-c8f1-4f2d-be6e-4d269b8c362c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 14, 2023
Manufacturers
FDA
Provepharm Inc.
DUNS: 086861066
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
physostigmine salicylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code81284-831
Product Classification
G
Generic Name
physostigmine salicylate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 14, 2023
FDA Product Classification
INGREDIENTS (5)
EDETATE SODIUMInactive
Code: MP1J8420LU
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PHYSOSTIGMINE SALICYLATEActive
Quantity: 0.4 mg in 1 mL
Code: 2046ZRO9VU
Classification: ACTIB